Clinical trialNCT03073473TerminatedObservational

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

SponsorCota Inc.Enrollment40Metastatic Breast CancerMetastatic Colon CancerMetastatic Lung CancerMetastatic MelanomaMetastatic Prostate CancerPancreatic Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Among patients with advanced (metastatic) cancers, detailed characterizations of the tumor utilizing genomic and proteonomic techniques may help guide treatment. It, however, remains unclear if these new diagnostic technologies truly influence clinical and economic outcomes. This study will evaluate if patients treated according to the results of the NantHealth GPS Cancer test achieve optimal outcomes compared to patients whose treatment are discordant with GPS Cancer recommendations.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Deena Atieh Graham, MD
Hackensack Meridian Health System
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Rcca - Central Jersey Division
East Brunswick, New Jersey, United States
Rcca - Freehold Division
Freehold, New Jersey, United States
Hackensack Meridian Health System
Hackensack, New Jersey, United States
Rcca - Hackettstown Division
Hackettstown, New Jersey, United States
Rcca - Howell Division
Howell Township, New Jersey, United States
Rcca - Little Silver Division
Little Silver, New Jersey, United States
Rcca - Marmora Division
Marmora, New Jersey, United States
Rcca - Mount Holly Division
Mount Holly, New Jersey, United States
Rcca - Pompton Plains Division
Pompton Plains, New Jersey, United States
Rcca - Sparta Division
Sparta, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 2017
Primary completion: 13 Jun 2018
Completion: 13 Jun 2018
Last update posted: 20 Jul 2018
Registered enrollment: 40
Registry id: NCT03073473

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.